Exit

A865 New Directions in Influenza Management: The Pharmacist’s Guide to Patient Identification, Testing, and Antiviral Use

Question Title

* 1. Please indicate the conference you will be attending (Select 1)

Question Title

* 2. According to current recommendations by the Centers for Disease Control and Prevention (CDC), when should antiviral therapy be initiated in high-risk patients with signs and symptoms of influenza?

a. Within 48 h of symptom onset

b. As early as possible (no specified time limit)

c. Only after laboratory testing confirms influenza

d. Only if the patient requires hospitalization

Question Title

* 3. A 47-year-old woman with mild COPD and BMI 40 kg/m2, and well-controlled hypertension presents with fever (101° F), cough, chills, and myalgias that began abruptly 2½ days ago. Her husband was recently diagnosed with influenza; however, she received the vaccination 1 month ago, and he did not. Based on this information, how many risk factors does this patient have for influenza, and should she receive antiviral therapy?

a. 0; no

b. 1; no

c. 1; yes

d. 2; yes

Question Title

* 4. How confident are you that you selected the correct response to question 3?

a. Not at all confident

b. Somewhat confident

c. Confident

d. Very confident

Question Title

* 5. Which of the following statements is TRUE of rapid influenza diagnostic tests (RIDTs)?

a. They are associated with a high rate of false negatives

b. They are the preferred test of the CDC

c. Results are needed to confirm influenza before antiviral treatment can be initiated

d. They are significantly less specific than RT-PCR (reverse transcriptase polymerase chain reaction) tests

Question Title

* 6. A 14-year-old boy presents during peak influenza season with sudden-onset fever (100.1° F), aches, chest discomfort, and headache 2 days ago. He tests negative for COVID-19; RIDT is negative for influenza, despite recent exposure at school. Relevant medical history includes intermittent asthma. Vitals and exam suggest he can be managed in the outpatient setting. Based on this information, what is the most appropriate course of action for this patient?

a. Prescribe antibiotic

b. Prescribe antiviral

c. Prescribe albuterol prn

d. Recommend supportive care

Question Title

* 7. How confident are you that you selected the correct response to question 6?

a. Not at all confident

b. Somewhat confident

c. Confident

d. Very confident

Question Title

* 8. Which of the following is a key finding that has been consistent across the CAPSTONE-1, CAPSTONE-2, and MINISTONE-2 trials?

a. Baloxavir and oseltamivir have a comparable half-life

b. Baloxavir reduces viral load more rapidly than oseltamivir in all populations studied

c. Baloxavir is associated with a higher incidence of gastrointestinal adverse events than oseltamivir

d. Baloxavir and oseltamivir have comparable time to improvement of influenza symptoms in high-risk patients with influenza B

Question Title

* 9. A 35-year-old woman presents with fatigue, myalgia, headache, and cough that started 2 d ago. She has several comorbid conditions (diabetes, nonalcoholic fatty liver disease, and severe obesity), and she notes frequent difficulty remembering to take all of her medications. The patient tests positive for influenza B on RT-PCR. What is the best treatment option for this patient?

a. Peramivir

b. Zanamivir

c. Oseltamivir

d. Baloxavir

Question Title

* 10. How confident are you that you selected the correct response to question 9?

a. Not at all confident

b. Somewhat confident

c. Confident

d. Very confident

Question Title

* 11. Please complete the following

Full Name

Question Title

* 12. Paradigm Medical Communications, LLC may email information about this and other continuing education activities to the email address indicated above

Yes